R1	Has_value Arg1:T5 Arg2:T4	
R2	Has_value Arg1:T3 Arg2:T4	
R3	Has_index Arg1:T6 Arg2:T7	
R4	Has_temporal Arg1:T4 Arg2:T6	
R5	Subsumes Arg1:T8 Arg2:T10	
R6	Subsumes Arg1:T8 Arg2:T11	
R7	Subsumes Arg1:T8 Arg2:T12	
T1	Person 0 5	Males
T2	Person 10 17	females
T3	Person 18 22	aged
T4	Value 23 34	18-40 years
T5	Person 38 41	age
T6	Temporal 42 68	at the time of vaccination
T7	Reference_point 49 68	time of vaccination
T8	Condition 72 83	good health
T9	Undefined_semantics 72 83	good health
T10	Temporal 101 116	medical history
T11	Procedure 118 131	physical exam
T12	Procedure 133 155	laboratory assessments
T13	Subjective_judgement 160 211	the clinical judgment of the Principal Investigator
T15	Non-query-able 213 374	Able to provide informed consent indicating that they understand the purpose of this study and are willing to adhere to the procedures described in this protocol
T16	Post-eligibility 376 916	If the subject is a female of childbearing potential, she must use adequate contraceptive precautions (e.g., intrauterine contraceptive device, oral contraceptives or other equivalent hormonal contraception) for 2 months prior to vaccination and continue to use such precautions for a minimum of three months after vaccination. She must also have a negative urine pregnancy test within 24 hours prior to receiving study vaccine. Women at least one year post-menopausal or surgically sterile will not be considered of childbearing potential.
T17	Non-query-able 918 984	Willing to receive the unlicensed vaccine given as an IM injection
T18	Drug 952 959	vaccine
T19	Procedure 972 984	IM injection
T20	Non-query-able 986 1055	Willing to provide multiple blood specimens collected by venipuncture
